Julie A. Johnson, PharmD
OFFICE: HPNP 4332
|BS||Ohio State University||Pharmacy|
|PharmD||University of Texas Austin & University of Texas||Pharmacy|
|Post-Doctoral Fellowship||Ohio State University||Cardiovascular Pharmacology/Pharmacokinetics|
- V. Ravi Chandran Professor of Pharmaceutical Sciences, Distinguished Professor of Pharmacy in the Department of Pharmacotherapy and Translational Research
- Professor of Medicine (Cardiovascular Medicine) at the University of Florida Colleges of Pharmacy and Medicine
- Director of the UF Center for Pharmacogenomics
- Director of the UF&Shands Personalized Medicine Program
Johnson joined the faculty at the University of Florida in May 1998. Prior to her appointment, she held a faculty position for nine years at the University of Tennessee College of Pharmacy.
Johnson’s research focus is cardiovascular drug pharmacogenomics, and disease-gene associations that may be relevant to pharmacogenomics, and the influence of race/ethnicity on drug response and pharmacogenomics. The majority of her research centers around efforts in hypertension, heart failure, with a primary focus on proteins that are drug targets and the impact of their genetic polymorphisms on drug response and disease. Her research has been continuously funded by the National Institutes of Health or the American Heart Association since 1990. She recently became a member of the NIH Pharmacogenetics Research Network, with a project focused on pharmacogenomics of antihypertensive drugs.
Johnson served on the Nonprescription Drugs Advisory Committee of the Food and Drug Administration (2000-2004), and is also serving a five year term on the Pediatric Heart Disease Clinical Research Network Protocol Review Committee for the National Heart Lung and Blood Institute at NIH. She also served as a Regent of the American College of Clinical Pharmacy (2000-2003). She is on the editorial boards of the journals Pharmacogenetics and Genomics, Clinical Pharmacology and Therapeutics and Personalized Medicine, is a scientific editor for Pharmacotherapy and serves as manuscript reviewer for numerous other scientific journals.
Please click here for a list of Julie Johnson’s industry relationships.